Chronic Insomnia Market to Witness Growth by 2032, Estimates DelveInsight | Janssen Research, Takeda

DelveInsight’s “Chronic Insomnia Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Chronic Insomnia.

DelveInsight’s “Chronic Insomnia Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Chronic Insomnia, historical and forecasted epidemiology as well as the Chronic Insomnia market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.


To Know in detail about the Chronic Insomnia market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Chronic Insomnia Market Forecast


Some of the key facts of the Chronic Insomnia Market Report

The Chronic Insomnia market size is anticipated to grow with a significant CAGR during the study period (2019-2032)
In the 7 MM countries, there will be 5,697,127 cases of chronic insomnia that have been diagnosed as of 2021
Age plays a significant role in how the disease develops. The age group of 20 to 29 years saw the highest number of cases in the US in 2021 with 474,746. Following this, there were 421,996 instances in the US for each of the age groups of 30-39 and 40-49 years
France had the greatest diagnosed prevalence of chronic insomnia among the European nations, with 890,539 cases. Germany came in second with 407,108 cases in 2021
Germany reported 207,625 instances of chronic insomnia in females and 199,483 cases in men among the EU5 nations in 2021
Key Chronic Insomnia Companies: Janssen Research & Development, Takeda, and others
Key Chronic Insomnia Therapies: Seltorexant, Ramelteon and zolpidem, and others
The Chronic Insomnia epidemiology based on gender analyzed that Chronic Insomnia is more prominent in females in comparison to males
The Chronic Insomnia market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Chronic Insomnia pipeline products will significantly revolutionize the Chronic Insomnia market dynamics.


Chronic Insomnia Overview

The most prevalent sleep condition, insomnia, has significant socioeconomic implications. Insomnia is defined by difficulty initiating, sustaining, or improving the quality of sleep, according to the International Classification of Sleep Disorders, third edition (ICSD-3). These symptoms cause daytime dysfunction even though there are good sleeping conditions and opportunities.


Get a Free sample for the Chronic Insomnia Market Report


Chronic Insomnia Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.


Chronic Insomnia Epidemiology Segmentation:

The Chronic Insomnia market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:

Total Prevalence of Chronic Insomnia
Prevalent Cases of Chronic Insomnia by severity
Gender-specific Prevalence of Chronic Insomnia
Diagnosed Cases of Episodic and Chronic Chronic Insomnia


Download the report to understand which factors are driving Chronic Insomnia epidemiology trends @ Chronic Insomnia Epidemiology Forecast


Chronic Insomnia Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Chronic Insomnia market or expected to get launched during the study period. The analysis covers Chronic Insomnia market uptake by drugs, patient uptake by therapies, and sales of each drug. 

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Chronic Insomnia Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.


Chronic Insom nia Therapies and Key Companies

Seltorexant: Janssen Research & Development
Ramelteon and zolpidem: Takeda


Discover more about therapies set to grab major Chronic Insomnia market share @ Chronic Insomnia Treatment Market


Chronic Insomnia Market Drivers

Increasing Prevalence
Personalization of therapies


Chronic Insomnia Market Barriers

Issues with diagnosis and poor knowledge
Use of off-label drugs
High economic burden


Scope of the Chronic Insomnia Market Report

Study Period: 2019–2032
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan] Key Chronic Insomnia Companies: Janssen Research & Development, Takeda, and others
Key Chronic Insomnia Therapies: Seltorexant, Ramelteon and zolpidem, and others
Chronic Insomnia Therapeutic Assessment: Chronic Insomnia current marketed and Chronic Insomnia emerging therapies
Chronic Insomnia Market Dynamics: Chronic Insomnia market drivers and Chronic Insomnia market barriers 
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
Chronic Insomnia Unmet Needs, KOL’s views, Analyst’s views, Chronic Insomnia Market Access and Reimbursement 


To know more about Chronic Insomnia companies working in the treatment market, visit @ Chronic Insomnia Clinical Trials and Therapeutic Assessment


Table of Contents 

1. Chronic Insomnia Market Report Introduction

2. Executive Summary for Chronic Insomnia

3. SWOT analysis of Chronic Insomnia

4. Chronic Insomnia Patient Share (%) Overview at a Glance

5. Chronic Insomnia Market Overview at a Glance

6. Chronic Insomnia Disease Background and Overview

7. Chronic Insomnia Epidemiology and Patient Population

8. Country-Specific Patient Population of Chronic Insomnia 

9. Chronic Insomnia Current Treatment and Medical Practices

10. Chronic Insomnia Unmet Needs

11. Chronic Insomnia Emerging Therapies

12. Chronic Insomnia Market Outlook

13. Country-Wise Chronic Insomnia Market Analysis (2019–2032)

14. Chronic Insomnia Market Access and Reimbursement of Therapies

15. Chronic Insomnia Market Drivers

16. Chronic Insomnia Market Barriers

17.  Chronic Insomnia Appendix

18. Chronic Insomnia Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight


About DelveInsight 

DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight Business Research
Contact Person: Gaurav Bora
Email: Send Email
Phone: 8774225362
Address:27 Drydock Ave S. Jones Blvd #2432
City: Boston
State: MA
Country: United States

Daily Digest Signup

Daily business and market business news, business management tips, market research insights, and more.


Smart public opinion research for everyone.

%d bloggers like this: